Point-of-care (POC) testing is essential to halt the spread of deadly infectious diseases (e.g., Ebola, Zika, etc.) and is needed for rapid and accurate screening both in and outside of clinical settings. Label-free bioassays are desirable for POC testing as they have fewer reagents and assay steps resulting in lower cost and ease of use. Biosensors based on electrochemical impedance spectroscopy (EIS), an ultra-sensitive, label-free sensing technique, are a promising technology for precise and rapid disease diagnosis at the point-of-care. However, EIS usually requires mixers and lock-in detection to measure both the magnitude and phase of the complex impedance.